Showing results (2371-2380 of 2,447) with videos related to
Sort By:
Pageof 245
Annals of Surgery|July 30, 2019
Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer CollaborativeLisa A Newman, Brittany Jenkins, Yalei Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2021
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic CancerJoseph E Grossman, Lakshmi Muthuswamy, Ling Huang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1996
The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adductsN Rothman, R B Hayes, T V Zenser, et al.Pain|October 26, 2000
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1Philip Hayes, Helen J Meadows, Martin J Gunthorpe, et al.BMC Health Services Research|September 2, 2020
Improving systems of care during and after a pregnancy complicated by hyperglycaemia: A protocol for a complex health systems interventionD MacKay, R Kirkham, N Freeman, et al.Cancers|October 27, 2022
The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate CancerDaisy B Haigh, Corinne L Woodcock, Jennifer Lothion-Roy, et al.Cancer Research Communications|April 21, 2023
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1AManjunath Siddappa, Shahid Hussain, Sajad A Wani, et al.Frontiers in Earth Science|May 23, 2020
Atmospheric Correction of Satellite Ocean-Color Imagery During the PACE EraRobert J Frouin, Bryan A Franz, Amir Ibrahim, et al.Biorxiv : the Preprint Server for Biology|December 11, 2023
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatmentFlorencia P Madorsky Rowdo, Gu Xiao, Galina F Khramtsova, et al.Nature Cancer|January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancerNadeem Riaz, Tyler J Alban, Robert I Haddad, et al.Pageof 245